Robert G. Mitchell, senior manager, contrast imaging solutions, explains how Bracco Diagnostics' acquisition of E-Z-EM further positions the company as a global leader in diagnostic imaging in radiology and cardiology. The merger allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.
If you enjoy this content, please share it with a colleague
Related Content
June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...
May 22, 2026 — The American College of Radiology (ACR) supports passage of the Medicare Access to Radiology Care Act (S ...
May 22, 2026 — U.S. Sens. Boozman, R-AR, and Luján, D-NM, have introduced the Medicare Access to Radiology Care Act ...
May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...
For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...
May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...
May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...
April 27, 2026 — SimonMed, one of the nation’s largest independent outpatient imaging providers, has announced the ...
April 23, 2026 — Royal Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...
June 01, 2026 